Pathogens,
Journal Year:
2021,
Volume and Issue:
10(5), P. 582 - 582
Published: May 11, 2021
Coronavirus
disease
2019
(COVID-19),
caused
by
severe
acute
respiratory
syndrome-coronavirus
2
(SARS-CoV-2),
has
been
recently
considered
a
systemic
disorder
leading
to
the
procoagulant
state.
Preliminary
studies
have
shown
that
SARS-CoV-2
can
infect
endothelial
cells,
and
extensive
evidence
of
inflammation
dysfunction
found
in
advanced
COVID-19.
Endothelial
cells
play
critical
role
many
physiological
processes,
such
as
controlling
blood
fluidity,
leukocyte
activation,
adhesion,
platelet
adhesion
aggregation,
transmigration.
Therefore,
it
is
reasonable
think
leads
vascular
dysfunction,
immune
thrombosis,
associated
with
This
article
summarizes
association
infection
its
therapeutic
strategies.
Frontiers in Immunology,
Journal Year:
2021,
Volume and Issue:
12
Published: Feb. 3, 2021
Sepsis
is
a
life-threatening
systemic
illness
attributed
to
dysregulated
host
response
infection.
global
burden
killing
~11
million
persons
annually.
In
December
2019,
novel
pneumonia
condition
termed
coronavirus
disease
2019
(COVID-19),
caused
by
severe
acute
respiratory
syndrome
2
(SARS-CoV-2),
emerged
and
has
resulted
in
more
than
1,535,982
deaths
globally
as
of
8th
2020.
These
two
conditions
share
many
pathophysiological
clinical
features.
Notably,
both
sepsis
COVID-19
patients
experience
consumptive
thrombocytopenia,
haemolytic
anaemia,
vascular
microthrombosis,
multi-organ
dysfunction
syndrome,
coagulopathy,
septic
shock,
failure,
fever,
leukopenia,
hypotension,
leukocytosis,
high
cytokine
production
predisposition
opportunistic
infections.
Considering
the
parallels
immunopathogenesis
manifestations
COVID-19,
it
highly
likely
that
care,
which
well-established
history
most
health
systems,
could
inform
on
management.
view
this,
present
perspective
compares
pathophysiology
non-SARS-CoV-2
induced
sepsis,
lessons
from
can
be
applicable
Arteriosclerosis Thrombosis and Vascular Biology,
Journal Year:
2020,
Volume and Issue:
41(3), P. 1032 - 1046
Published: Dec. 31, 2020
Innate
immune
cells
can
develop
exacerbated
immunologic
response
and
long-term
inflammatory
phenotype
following
brief
exposure
to
endogenous
or
exogenous
insults,
which
leads
an
altered
towards
a
second
challenge
after
the
return
nonactivated
state.
This
phenomenon
is
known
as
trained
immunity
(TI).
TI
not
only
important
for
host
defense
vaccine
but
also
chronic
inflammations
such
cardiovascular
metabolic
diseases
atherosclerosis.
occur
in
innate
monocytes/macrophages,
natural
killer
cells,
endothelial
(ECs),
nonimmune
fibroblast.
In
this
review,
we
analyze
significance
of
ECs,
are
considered
addition
macrophages.
be
induced
by
variety
stimuli,
including
lipopolysaccharides,
BCG
(bacillus
Calmette-Guerin),
oxLDL
(oxidized
low-density
lipoprotein),
defined
risk
factors
diseases.
Furthermore,
ECs
functional
inflammation
effectiveness
transition
inflammation.
Rewiring
cellular
metabolism
takes
place
during
induction
TI,
increased
glycolysis,
glutaminolysis,
accumulation
tricarboxylic
acid
cycle
metabolites
acetyl-coenzyme
A
production,
well
mevalonate
synthesis.
Subsequently,
epigenetic
remodeling,
resulting
changes
chromatin
architecture
that
enables
gene
transcription
enhanced
proinflammatory
response.
However,
pathways
separated
ensure
memory
stays
when
undergoes
resolution.
Additionally,
reactive
oxygen
species
play
context-dependent
roles
TI.
Therefore,
plays
significant
EC
macrophage
pathology
further
characterization
macrophages
would
provide
novel
insights
into
disease
pathogenesis
new
therapeutic
targets.
Graphic
Abstract:
graphic
abstract
available
article.
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(12), P. 6574 - 6574
Published: June 18, 2021
Heparan
sulfate
proteoglycans
(HSPGs)
encompass
a
group
of
glycoproteins
composed
unbranched
negatively
charged
heparan
(HS)
chains
covalently
attached
to
core
protein.
The
complex
HSPG
biosynthetic
machinery
generates
an
extraordinary
structural
variety
HS
that
enable
them
bind
plethora
ligands,
including
growth
factors,
morphogens,
cytokines,
chemokines,
enzymes,
matrix
proteins,
and
bacterial
viral
pathogens.
These
interactions
translate
into
key
regulatory
activity
HSPGs
on
wide
range
cellular
processes
such
as
receptor
activation
signaling,
cytoskeleton
assembly,
extracellular
remodeling,
endocytosis,
cell-cell
crosstalk,
others.
Due
their
ubiquitous
expression
within
tissues
large
functional
repertoire,
are
involved
in
many
physiopathological
processes;
thus,
they
have
emerged
valuable
targets
for
the
therapy
human
diseases.
Among
functions,
assist
viruses
invading
host
cells
at
various
steps
life
cycle.
Viruses
utilize
attachment
cell,
internalization,
intracellular
trafficking,
egress,
spread.
Recently,
involvement
pathogenesis
SARS-CoV-2
infection
has
been
established.
Here,
we
summarize
current
knowledge
molecular
mechanisms
underlying
HSPG/SARS-CoV-2
interaction
downstream
effects,
provide
overview
HSPG-based
therapeutic
strategies
could
be
used
combat
fearsome
virus.
Frontiers in Public Health,
Journal Year:
2021,
Volume and Issue:
9
Published: July 28, 2021
SARS-CoV-2
started
spreading
toward
the
end
of
2019
causing
COVID-19,
a
disease
that
reached
pandemic
proportions
among
human
population
within
months.
The
reasons
for
spectrum
differences
in
severity
across
population,
and
particular
why
affects
more
severely
aging
those
with
specific
preconditions
are
unclear.
We
developed
machine
learning
models
to
mine
240,000
scientific
articles
openly
accessible
CORD-19
database,
constructed
knowledge
graphs
synthesize
extracted
information
navigate
collective
an
attempt
search
potential
common
underlying
reason
severity.
machine-driven
framework
we
repeatedly
pointed
elevated
blood
glucose
as
key
facilitator
progression
COVID-19.
Indeed,
when
systematically
retraced
steps
infection,
found
evidence
linking
each
major
step
life-cycle
virus,
disease,
presentation
symptoms.
Specifically,
elevations
provide
ideal
conditions
virus
evade
weaken
first
level
immune
defense
system
lungs,
gain
access
deep
alveolar
cells,
bind
ACE2
receptor
enter
pulmonary
accelerate
replication
cells
increasing
cell
death
inducing
inflammatory
response,
which
overwhelms
already
weakened
innate
trigger
avalanche
systemic
infections,
inflammation
damage,
cytokine
storm
thrombotic
events.
tested
feasibility
hypothesis
by
manually
reviewing
literature
referenced
machine-generated
synthesis,
reconstructing
atomistically
at
surface
airways,
performing
quantitative
computational
modeling
effects
levels
on
infection
process.
conclude
elevation
can
facilitate
through
multiple
mechanisms
explain
much
seen
population.
study
provides
diagnostic
considerations,
new
areas
research
treatments,
cautions
treatment
strategies
critical
care
induce
levels.
Life,
Journal Year:
2022,
Volume and Issue:
12(10), P. 1605 - 1605
Published: Oct. 14, 2022
SARS-CoV-2,
a
novel
coronavirus
found
in
Wuhan
(China)
at
the
end
of
2019,
is
etiological
agent
current
pandemic
that
heterogeneous
disease,
named
disease
2019
(COVID-19).
SARS-CoV-2
affects
primarily
lungs,
but
it
can
induce
multi-organ
involvement
such
as
acute
myocardial
injury,
myocarditis,
thromboembolic
eventsandrenal
failure.
Hypertension,
chronic
kidney
diabetes
mellitus
and
obesity
increase
risk
severe
complications
COVID-19.
There
no
certain
explanation
for
this
systemic
COVID-19
involvement,
could
be
related
to
endothelial
dysfunction,
due
direct
(endothelial
cells
are
infected
by
virus)
indirect
damage
(systemic
inflammation)
factors.
Angiotensin-converting
enzyme
2
(ACE2),
expressed
human
endothelium,
has
fundamental
role
respiratory
syndrome
(SARS-CoV-2)
infection.
In
fact,
ACE2
used
receptor
leading
downregulation
these
receptors
on
cells;
once
inside,
virus
reduces
integrity
tissue,
with
exposure
prothrombotic
molecules,
platelet
adhesion,
activation
coagulation
cascades
and,
consequently,
vascular
damage.
Systemic
microangiopathy
thromboembolism
lead
failure
an
elevated
death.
Considering
crucial
immunological
response
developing
form
COVID-19,
review,
we
will
attempt
clarify
underlying
pathophysiological
mechanisms.
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(21), P. 11920 - 11920
Published: Nov. 3, 2021
The
2019
novel
coronavirus,
known
as
severe
acute
respiratory
syndrome-coronavirus
2
(SARS-CoV-2)
or
coronavirus
disease
(COVID-19),
is
causing
a
global
pandemic.
virus
primarily
affects
the
upper
and
lower
tracts
raises
risk
of
variety
non-pulmonary
consequences,
most
possibly
fatal
which
are
cardiovascular
problems.
Data
show
that
almost
one-third
patients
with
moderate
form
COVID-19
had
preexisting
comorbidities
such
diabetes
mellitus,
obesity,
hypertension,
heart
failure,
coronary
artery
disease.
SARS-CoV2
causes
hyper
inflammation,
hypoxia,
apoptosis,
renin-angiotensin
system
imbalance
in
cell
types,
endothelial
cells.
Profound
dysfunction
associated
can
be
cause
impaired
organ
perfusion
may
generate
myocardial
injury,
renal
procoagulant
state
resulting
thromboembolic
events.
We
discuss
recent
results
on
involvement
pathogenesis
cardiometabolic
diseases
this
review.
also
provide
insights
treatments
reduce
severity
viral
infection.
Stem Cell Research,
Journal Year:
2021,
Volume and Issue:
51, P. 102168 - 102168
Published: Jan. 14, 2021
COVID-19
caused
by
a
novel
coronavirus
named
SARS-CoV-2,
can
elites
severe
acute
respiratory
syndrome,
lung
injury,
cardiac
and
even
death
became
worldwide
pandemic.
SARS-CoV-2
infection
may
result
in
injury
via
several
mechanisms,
including
the
expression
of
angiotensin-converting
enzyme
2
(ACE2)
receptor
leading
to
cytokine
storm,
elicit
an
exaggerated
host
immune
response.
This
response
contributes
multi-organ
dysfunction.
As
emerging
infectious
disease,
there
are
limited
data
on
effects
this
patients
with
underlying
cardiovascular
comorbidities.
In
review,
we
summarize
early-stage
clinical
experiences
COVID-19,
particular
focus
diseases
cardiopulmonary
injuries,
explores
potential
available
evidence
regarding
association
between
complications.
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(13), P. 7135 - 7135
Published: July 1, 2021
Parkinson’s
disease
(PD)
is
the
most
common
neurodegenerative
motor
disorder
characterized
by
selective
degeneration
of
dopaminergic
neurons
in
substantia
nigra
pars
compacta
(SNpc)
midbrain,
depletion
dopamine
(DA),
and
impaired
nigrostriatal
pathway.
The
pathological
hallmark
PD
includes
aggregation
accumulation
α-synuclein
(α-SYN).
Although
precise
mechanisms
underlying
pathogenesis
are
still
unknown,
activation
toll-like
receptors
(TLRs),
mainly
TLR4
subsequent
neuroinflammatory
immune
response,
seem
to
play
a
significant
role.
Mounting
evidence
suggests
that
viral
infection
can
concur
with
precipitation
or
parkinsonism.
recently
identified
coronavirus
named
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
causative
agent
ongoing
pandemic
2019
(COVID-19),
responsible
for
160
million
cases
led
death
more
than
three
individuals
worldwide.
Studies
have
reported
many
patients
COVID-19
display
several
neurological
manifestations,
including
cerebrovascular
diseases,
conscious
disturbance,
typical
non-motor
symptoms
accompanying
PD.
In
this
review,
neurotropic
potential
SARS-CoV-2
its
possible
involvement
discussed.
Specifically,
signaling
pathway
mediating
virus
entry,
as
well
massive
inflammatory
response
explored.
binding
spike
(S)
protein
interaction
between
α-SYN
contributing
factors
neuronal
also
considered.